SCHEMBL25430889

SCHEMBL25430889

Cn1nc(N)c(C2CCC2)c1C1CC(F)(F)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25432293 0.87 KDM1A (0.30) —
SCHEMBL25430953 0.76 CHEK1 (0.32) —
SCHEMBL31593420 0.72 TYK2 (0.31) —
SCHEMBL31593564 0.72 GRM4 (0.32) —
SCHEMBL31593546 0.72 TYK2 (0.31) —
SCHEMBL31593559 0.71 DGAT1 (0.31) —
SCHEMBL31593681 0.71 SMN1; SMN2 (0.34) —
SCHEMBL31593481 0.70 SMN1; SMN2 (0.39) —
SCHEMBL25432205 0.69 GAA (0.33) —
SCHEMBL26054414 0.69 CYP1A2 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250230152-A1 PYRAZOLYL COMPOUNDS AS KV7 CHANNEL ACTIVATORS BIOHAVEN THERAPEUTICS LTD (US) 2025-07-17 — — US disclosed
US-20250171429-A1 PYRAZOLYL COMPOUNDS AS KV7 CHANNEL ACTIVATORS BIOHAVEN THERAPEUTICS LTD (US) 2025-05-29 — — US disclosed
EP-4482489-A1 PYRAZOLYL COMPOUNDS AS KV7 CHANNEL ACTIVATORS Biohaven Therapeutics Ltd. (US) 2025-01-01 — — EP disclosed
CN-118695860-A Pyrazolyl compounds as KV7 channel activators 拜奥海芬治疗学有限公司 2024-09-24 — — CN disclosed
WO-2023164536-A1 PYRAZOLYL COMPOUNDS AS KV7 CHANNEL ACTIVATORS BIOHAVEN THERAPEUTICS LTD. (US) 2023-08-31 — — WO disclosed
WO-2023164536-A1 PYRAZOLYL COMPOUNDS AS KV7 CHANNEL ACTIVATORS BIOHAVEN THERAPEUTICS LTD. (US) 2023-08-31 — — WO disclosed
Send feedback